Research Proofs Efficacy of Silver-based Cancer Drug

Primary tabs

Research Proofs Efficacy of Silver-based Cancer Drug
Fecha de publicación: 
31 March 2018
Imagen principal: 

Silver-based drugs become a more effective and safe treatment for esophagus cancer and other oncological lesions, according to a study published today in the BioMetals journal.

To demonstrate this thesis, experts from the University of Johannesburg (South Africa), investigated the effects of a new chemotherapy in both animal models -rats- and in human cell cultures (CCH).

The novelty, UJ3, a complex of silver thiocyanate phosphine, is as positive as cisplatin in killing breast cancer and melanoma cells in CCH, said main author Marianne Cronjé.

However, he added, UJ3 requires a dose up to 10 times lower to kill these cancer cells, and as it has a greater specificity on the tumor ones, the healthy ones destroyed during the treatment is noticeably lower.

If UJ3 becomes a chemotherapeutic drug in the future, the need for a lower dose, minimal toxicity and greater specificity for tumor cells will make it possible to treat cancer with fewer side effects, emphasized the authors.

Add new comment

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Enter the characters shown in the image.

Image gallery